The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Progression of Symptoms in the Early and Middle Stages of Huntington Disease
Abstract
OBJECTIVE: To delineate the progression of symptoms in the early and middle stages of Huntington disease (HD). DESIGN: A survey of individuals with symptomatic HD completed by a first-degree relative. SETTING: The National Huntington Disease Research Roster for Patients and Families, Indianapolis, Ind. PARTICIPANTS: The survey included 1238 individuals with a minimum of a 6-year history of symptomatic HD. MEASURES: Participating families completed a series of surveys, including the Affected Individual Questionnaire, which consists of 19 physical, emotional, and cognitive signs commonly thought to occur during disease progression. The respondent indicates if each of the symptoms occurred and, if so, at what time during the course of the disease: (1) within 1 year, (2) within 2 to 5 years, (3) within 6 to 10 years, (4) after more than 10 years, (5) has not occurred, or (6) "don't know." RESULTS: The symptoms are categorized into 6 onset periods. Involuntary movements are grouped alone as the earliest reported symptom. The second group is composed entirely of mental and emotional symptoms, including sadness, depression, and difficult to get along with. The third group includes clumsiness, sexual problems, lack of motivation, and suspiciousness/paranoia. As the disease progresses, a variety of motor, emotional/behavioral, and cognitive symptoms are experienced, including unsteadiness, trouble holding onto things, trouble walking, changes in sleeping patterns, delusions and hallucinations, intellectual decline, and memory loss. With the approach of late-stage HD, affected individuals begin to experience speech difficulty and weight loss. In the late stage, patients lose bowel and bladder control. CONCLUSIONS: Even though the symptoms of HD are fairly well characterized, their progression, especially in the early and middle stages, remains uncertain. Clarification of the disease progression is vital to improved understanding of the pathogenesis of HD and to the evaluation of therapeutic agents that are designed to slow the progression of disease. The results of this study assist in clarifying HD progression from early involuntary movements and emotional changes to more overt motor symptoms and difficulty with activities of daily living.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
MACDONALD, M. (1993) · Cell · doi:10.1016/0092-8674(93)90585-e · Cited by 8,366
Regression Models for Ordinal Data
McCullagh, P. (1980) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1980.tb01109.x · Cited by 4,453
Unified Huntington's disease rating scale: Reliability and consistency
(1996) · Movement Disorders · doi:10.1002/mds.870110204 · Cited by 2,079
Unified Huntington's disease rating scale: reliability and consistency
Kremer, H. P. H. (1996) · Radboud Repository (Radboud University) · Cited by 1,059
Huntington disease: Clinical care and evaluation
Shoulson, I., & Fahn, S. (1979) · Neurology · doi:10.1212/wnl.29.1.1 · Cited by 746
Relationship between trinucleotide repeat expansion and phenotypic variation in Huntington's disease
Snell, R. G., MacMillan, J. C., Cheadle, J. P., Fenton, I., Lazarou, L. P., Davies, P., MacDonald, M. E., Gusella, J. F., Harper, P. S., & Shaw, D. J. (1993) · Nature Genetics · doi:10.1038/ng0893-393 · Cited by 709
Flier, J. S., Underhill, L. H., Martin, J. B., & Gusella, J. F. (1986) · New England Journal of Medicine · doi:10.1056/nejm198611133152006 · Cited by 550
Executive and mnemonic functions in early Huntington's disease
Lawrence, A. D., Sahakian, B. J., Hodges, J. R., Rosser, A. E., Lange, K. W., & Robbins, T. W. (1996) · Brain · doi:10.1093/brain/119.5.1633 · Cited by 386
Motor disorder in Huntington's disease begins as a dysfunction in error feedback control
Smith, M. A., Brandt, J., & Shadmehr, R. (2000) · Nature · doi:10.1038/35000576 · Cited by 354
Huntington's disease : a disorder of families
Folstein, S. E. (1989) · Johns Hopkins University Press eBooks · Cited by 315
Genetic instabilities and hereditary neurological diseases
Wells, R. D., Warren, S. T., & Sarmiento, M. (1998) · Cited by 269
Huntington's disease in venezuela: 7 years of follow‐up on symptomatic and asymptomatic individuals
Penney, J. B., Young, A. B., Shoulson, I., Starosta‐Rubenstein, S., Snodgrass, S. R., Sanchez‐Ramos, J., Ramos‐Arroyo, M., Gomez, F., Penchaszadeh, G., Alvir, J., et al. (1990) · Movement Disorders · doi:10.1002/mds.870050202 · Cited by 218
Self-citationCalkins, R. A., & Allen, M. W. V. (1967) · PubMed · Cited by 204
Huntington's disease in Venezuela: Neurologic features and functional decline
Young, A. B., Shoulson, I., Penney, J. B., Starosta-Rubinstein, S., Gomez, F., Travers, H., Ramos-Arroyo, M. A., Snodgrass, S. R., Bonilla, E., Moreno, H., et al. (1986) · Neurology · doi:10.1212/wnl.36.2.244 · Cited by 179
The measurement of abnormal movement: methods developed for Huntington's disease.
Folstein, S. E., Jensen, B. A., Leigh, R. J., & Folstein, M. F. (1983) · PubMed · Cited by 148
Cognitive scores in carriers of huntington's disease gene compared to noncarriers
Foroud, T., Siemers, E., Kleindorfer, D., Bill, D. J., Hodes, M. E., Norton, J. A., Conneally, P. M., & Christian, J. C. (1995) · Annals of Neurology · doi:10.1002/ana.410370516 · Cited by 113
Self-citationLongitudinal Cognitive and Motor Changes Among Presymptomatic Huntington Disease Gene Carriers
Close, S. L., Siemers, E., Stout, J. C., Hodes, M. E., Conneally, P. M., Christian, J. C., & Foroud, T. (1999) · Archives of Neurology · doi:10.1001/archneur.56.5.563 · Cited by 104
Self-citationŠidák, Z. (1971) · The Annals of Mathematical Statistics · doi:10.1214/aoms/1177693504 · Cited by 102
Presymptomatic Neuropsychological Impairment in Huntington's Disease
Jason, G. W., Pajurkova, E. M., Suchowersky, O., Hewitt, J., Hilbert, C., Reed, J., & Hayden, M. R. (1988) · Archives of Neurology · doi:10.1001/archneur.1988.00520310079021 · Cited by 91
Giordani, B., Berent, S., Boivin, M. J., Penney, J. B., Lehtinen, S., Markel, D. S., Hollingsworth, Z. R., Butterbaugh, G. J., Hichwa, R. D., Gusella, J. F., et al. (1995) · Archives of Neurology · doi:10.1001/archneur.1995.00540250063014 · Cited by 91
Characteristics of individuals with Huntington disease in long‐term care
Nance, M., & Sanders, G. (1996) · Movement Disorders · doi:10.1002/mds.870110509 · Cited by 87
Cognitive and Motor Correlates of Everyday Functioning in Early Huntington??s Disease
ROTHLIND, J. C., Bylsma, F., Peyser, C. E., Folstein, S. E., & Brandt, J. (1993) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-199303000-00008 · Cited by 75
Early Cognitive and Motor Symptoms in Identified Carriers of the Gene for Huntington Disease
de Boo, G. M., Tibben, A., Lanser, J. B. K., Jennekens-Schinkel, A., Hermans, J., Maat‐Kievit, A., & Roos, R. A. C. (1997) · Archives of Neurology · doi:10.1001/archneur.1997.00550230030012 · Cited by 72
Motor Changes in Presymptomatic Huntington Disease Gene Carriers
Siemers, E., Foroud, T., Bill, D. J., Sorbel, J., Norton, J. A., Hodes, M. E., Niebler, G. E., Conneally, P. M., & Christian, J. C. (1996) · Archives of Neurology · doi:10.1001/archneur.1996.00550060029011 · Cited by 71
Self-citationConfirmation of Subtle Motor Changes Among Presymptomatic Carriers of the Huntington Disease Gene
Close, S. L., Siemers, E., Bond, C. E., Conneally, P. M., Christian, J. C., & Foroud, T. (2000) · Archives of Neurology · doi:10.1001/archneur.57.7.1040 · Cited by 69
Self-citationStrauss, M. E., & Brandt, J. (1990) · Archives of Neurology · doi:10.1001/archneur.1990.00530080093016 · Cited by 52
Blackmore, L., Simpson, S. A., & Crawford, J. (1995) · Journal of Medical Genetics · doi:10.1136/jmg.32.5.358 · Cited by 47
Cited by
A comprehensive review of amyotrophic lateral sclerosis
Zarei, S., Carr, K., Reiley, L., Diaz, K., Guerra, O., Altamirano, P., Pagani, W., Lodin, D., Orozco, G., & Chinea, A. (2015) · Surgical Neurology International · doi:10.4103/2152-7806.169561 · Cited by 709
Mechanisms of neurodegeneration in Huntington’s disease
Gil, J. M., & Rego, A. C. (2008) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2008.06310.x · Cited by 471
Shirendeb, U., Reddy, A. P., Manczak, M., Calkins, M. J., Mao, P., Tagle, D. A., & Hemachandra Reddy, P. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr024 · Cited by 409
Shirendeb, U. P., Calkins, M. J., Manczak, M., Anekonda, V., Dufour, B., McBride, J. L., Mao, P., & Reddy, P. H. (2012) · Human Molecular Genetics · doi:10.1093/hmg/ddr475 · Cited by 383
Choosing an animal model for the study of Huntington's disease
Pouladi, M. A., Morton, A. J., & Hayden, M. R. (2013) · Nature Reviews Neuroscience · doi:10.1038/nrn3570 · Cited by 356
Metadata
- Authors
- Kirkwood, S. C., Su, J. L., Conneally, P. M., & Foroud, T.
- Venue
- Archives of Neurology
- Publisher
- American Medical Association (AMA)
- Published
- 2001-02-01
- Volume
- 58
- Issue
- 2
- Pages
- 273
- ISSN
- 0003-9942 (ISSN-L)
- OpenAlex
- W1967627236
- Cited by
- 269
- References
- 27
- FWCI
- 1.62
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.